To view this email as a web page,
click here Breaking News | | | Tuesday, February 26, 2019 It didn't take long for sparks to fly Tuesday when the cadre of Big Pharma executives sat down before the Senate Finance Committee to defend their price-setting decisions. But some CEOs had to scramble more than others. |
|
|
| | | Tuesday, February 26, 2019 The current structure of reimbursement for drugs in the U.S. is “regressive” and ultimately hurting patients, pharmaceutical executives said Tuesday at a Senate hearing. |
|
|
|
|
